| Literature DB >> 26226913 |
Zongwen Jin1, Daniel Geißler2, Xue Qiu1, K David Wegner1, Niko Hildebrandt3.
Abstract
The importance of microRNA (miRNA) dysregulation for the development and progression of diseases and the discovery of stable miRNAs in peripheral blood have made these short-sequence nucleic acids next-generation biomarkers. Here we present a fully homogeneous multiplexed miRNA FRET assay that combines careful biophotonic design with various RNA hybridization and ligation steps. The single-step, single-temperature, and amplification-free assay provides a unique combination of performance parameters compared to state-of-the-art miRNA detection technologies. Precise multiplexed quantification of miRNA-20a, -20b, and -21 at concentrations between 0.05 and 0.5 nM in a single 150 μL sample and detection limits between 0.2 and 0.9 nM in 7.5 μL serum samples demonstrate the feasibility of both high-throughput and point-of-care clinical diagnostics.Entities:
Keywords: FRET; clinical diagnostics; microRNA; multiplexing; time-gated fluorescence detection
Mesh:
Substances:
Year: 2015 PMID: 26226913 DOI: 10.1002/anie.201504887
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336